Abbvie Inc
NYSE:ABBV

Watchlist Manager
Abbvie Inc Logo
Abbvie Inc
NYSE:ABBV
Watchlist
Price: 187.585 USD 0.13%
Market Cap: 331.4B USD

Intrinsic Value

The intrinsic value of one ABBV stock under the Base Case scenario is 159.695 USD. Compared to the current market price of 187.585 USD, Abbvie Inc is Overvalued by 15%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ABBV Intrinsic Value
159.695 USD
Overvaluation 15%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Abbvie Inc

Valuation History Unavailable

Historical valuation for ABBV cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
Bear Theses

With Humira’s patent protection expiring in key markets, AbbVie faces an impending revenue cliff that may be difficult to replace with newer therapies in the short term, potentially straining cash flows and earnings.

Bull Theses

Skyrizi and Rinvoq have shown strong clinical data and commercial traction, signifying AbbVie’s potential to sustain leadership in immunology and mitigate the Humira patent cliff through these next-generation therapies.

Show More Less
How do you feel about ABBV?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Abbvie Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Abbvie Inc

Current Assets 27.7B
Cash & Short-Term Investments 5.2B
Receivables 12.5B
Other Current Assets 10B
Non-Current Assets 108.5B
Long-Term Investments 287m
PP&E 5.2B
Intangibles 93.8B
Other Non-Current Assets 9.2B
Efficiency

Free Cash Flow Analysis
Abbvie Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Abbvie Inc

Revenue
57.4B USD
Cost of Revenue
-16.8B USD
Gross Profit
40.6B USD
Operating Expenses
-23.1B USD
Operating Income
17.5B USD
Other Expenses
-13.3B USD
Net Income
4.2B USD
Fundamental Scores

ABBV Profitability Score
Profitability Due Diligence

Abbvie Inc's profitability score is 75/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Positive Free Cash Flow
Positive Gross Profit
Exceptional ROE
75/100
Profitability
Score

Abbvie Inc's profitability score is 75/100. The higher the profitability score, the more profitable the company is.

ABBV Solvency Score
Solvency Due Diligence

Abbvie Inc's solvency score is 29/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Average Altman Z-Score
Short-Term Solvency
Average Interest Coverage
29/100
Solvency
Score

Abbvie Inc's solvency score is 29/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ABBV Price Targets Summary
Abbvie Inc

Wall Street analysts forecast ABBV stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ABBV is 216.707 USD with a low forecast of 171.7 USD and a high forecast of 263.55 USD.

Lowest
Price Target
171.7 USD
8% Downside
Average
Price Target
216.707 USD
16% Upside
Highest
Price Target
263.55 USD
40% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for ABBV is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

ABBV Insider Trading
Buy and sell transactions by insiders

ABBV News

Other Videos
What is the Intrinsic Value of one ABBV stock?

The intrinsic value of one ABBV stock under the Base Case scenario is 159.695 USD.

Is ABBV stock undervalued or overvalued?

Compared to the current market price of 187.585 USD, Abbvie Inc is Overvalued by 15%.

Back to Top